Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-15 Sale | 2023-12-19 6:00 pm | IMPEL PHARMACEUTICALS INC | IMPL | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 575,000 | $0.12892 | $74,131 | 280,294 (Indirect) | View |
| 2021-11-19 Purchase | 2021-11-22 5:05 pm | IMPEL NEUROPHARMA INC | IMPL | NELSON TIMOTHY S Director | 10,000 | $10.76 | $107,554 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Other | 2024-04-09 4:20 pm | N/A 2029-11-20 | IPI Legacy Liquidation Co | IMPLQ | Wilfong Diane E. Director | 68,867 | $0 | 0 (Direct) | View |
| 2024-04-05 Other | 2024-04-09 4:19 pm | N/A 2027-02-13 | IPI Legacy Liquidation Co | IMPLQ | NELSON TIMOTHY S Director | 85,192 | $0 | 10,000 (Direct) | View |
| 2024-04-05 Other | 2024-04-09 4:17 pm | N/A 2031-07-10 | IPI Legacy Liquidation Co | IMPLQ | Allison David D. Director | 37,511 | $0 | 0 (Direct) | View |
| 2023-11-30 Other | 2023-12-04 9:00 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | BROOKFIELD Corp BAM Partners Trust Brookfield Asset Management ULC 10% Owner | 445,294 | $0 | 3,117,057 (Indirect) | View |
| 2023-11-30 Other | 2023-12-04 9:00 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Oaktree GCP Fund Delaware Holdings L.P. Oaktree Diversified Income Fund Inc. Oaktree AZ Strategic Lending Fund L.P. Oaktree Loan Acquisition Fund L.P. Oaktree LSL Fund Holdings EURRC S.a.r.l. Oaktree LSL Fund Delaware Holdings EURRC L.P. Oaktree PRE Life Sciences Fund L.P. Oaktree Capital Group LLC Atlas OCM Holdings LLC 10% Owner | 445,294 | $0 | 3,117,057 (Indirect) | View |
| 2023-11-30 Other | 2023-12-04 9:00 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Oaktree-TCDRS Strategic Credit LLC Oaktree-Forrest Multi-Strategy LLC Oaktree-TBMR Strategic Credit Fund C LLC Oaktree-TBMR Strategic Credit Fund F LLC Oaktree-TBMR Strategic Credit Fund G LLC Oaktree-TSE 16 Strategic Credit LLC INPRS Strategic Credit Holdings LLC Oaktree Gilead Investment Fund AIF (Delaware) L.P. Oaktree Specialty Lending Corp Oaktree Strategic Credit Fund 10% Owner | 445,294 | $0 | 3,117,057 (Indirect) | View |
Ownership | 2023-11-20 9:16 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | BROOKFIELD Corp BAM Partners Trust Brookfield Asset Management ULC 10% Owner | 0 | $0 | 2,671,763 (Indirect) | View |
Ownership | 2023-11-20 9:12 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Oaktree GCP Fund Delaware Holdings L.P. Oaktree Diversified Income Fund Inc. Oaktree AZ Strategic Lending Fund L.P. Oaktree Loan Acquisition Fund L.P. Oaktree LSL Fund Holdings EURRC S.a.r.l. Oaktree LSL Fund Delaware Holdings EURRC L.P. Oaktree PRE Life Sciences Fund L.P. Oaktree Capital Group LLC Atlas OCM Holdings LLC 10% Owner | 0 | $0 | 2,671,763 (Indirect) | View |
Ownership | 2023-11-20 9:09 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Oaktree-TCDRS Strategic Credit LLC Oaktree-Forrest Multi-Strategy LLC Oaktree-TBMR Strategic Credit Fund C LLC Oaktree-TBMR Strategic Credit Fund F LLC Oaktree-TBMR Strategic Credit Fund G LLC Oaktree-TSE 16 Strategic Credit LLC INPRS Strategic Credit Holdings LLC Oaktree Gilead Investment Fund AIF (Delaware) L.P. Oaktree Specialty Lending Corp Oaktree Strategic Credit Fund 10% Owner | 0 | $0 | 2,671,763 (Indirect) | View |
| 2023-06-16 Option Award | 2023-06-20 6:41 pm | N/A 2033-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director | 13,222 | $0 | 13,222 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 6:39 pm | N/A 2033-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | Wilfong Diane E. Director | 13,222 | $0 | 13,222 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 6:38 pm | N/A 2033-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | SHAH MAHENDRA Director | 13,222 | $0 | 13,222 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 6:37 pm | N/A 2033-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | NELSON TIMOTHY S Director | 13,222 | $0 | 13,222 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 6:36 pm | N/A 2033-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | Allison David D. Director | 13,222 | $0 | 13,222 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:41 pm | N/A 2033-05-10 | IMPEL PHARMACEUTICALS INC | IMPL | Kalb Michael Wayne CFO | 222,500 | $0 | 222,500 (Direct) | View |
Ownership | 2023-05-12 4:22 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Kalb Michael Wayne CFO | 0 | $0 | 0 (Direct) | View |
| 2023-04-12 Option Award | 2023-04-14 4:58 pm | N/A 2033-04-11 | IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director | 20,013 | $0 | 20,013 (Direct) | View |
Ownership | 2023-04-13 6:10 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Cline Darren S Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2023-03-10 4:33 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Amin Rajiv VP, Controller & Interim CFO | 0 | $0 | 45,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 6:23 pm | N/A 2033-02-13 | IMPEL PHARMACEUTICALS INC | IMPL | Paolillo Leonard Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 6:22 pm | N/A 2033-02-13 | IMPEL PHARMACEUTICALS INC | IMPL | Hoekman John Chief Scientific Officer | 42,500 | $0 | 42,500 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 6:20 pm | N/A 2033-02-13 | IMPEL PHARMACEUTICALS INC | IMPL | Leaman John Harold Chief Fin. & Business Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 6:19 pm | N/A 2033-02-13 | IMPEL PHARMACEUTICALS INC | IMPL | ADAMS ADRIAN COB, CEO and President | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 6:46 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Leaman John Harold Chief Fin. & Business Officer | 3,627 | $3.75 | 6,944 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-04 6:46 pm | N/A N/A | IMPEL PHARMACEUTICALS INC | IMPL | Leaman John Harold Chief Fin. & Business Officer | 10,571 | $0 | 6,944 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:06 pm | N/A 2032-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | Wilfong Diane E. Director | 12,789 | $0 | 12,789 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:05 pm | N/A 2032-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | SHAH MAHENDRA Director | 12,789 | $0 | 12,789 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:03 pm | N/A 2032-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | NELSON TIMOTHY S Director | 12,789 | $0 | 12,789 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:02 pm | N/A 2032-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | PARKER H STEWART Director | 12,789 | $0 | 12,789 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 5:00 pm | N/A 2032-06-15 | IMPEL PHARMACEUTICALS INC | IMPL | Allison David D. Director | 12,789 | $0 | 12,789 (Direct) | View |
| 2022-03-29 Exercise | 2022-03-30 9:54 pm | N/A 2027-02-13 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 24,606 | $0 | 97,990 (Direct) | View |
| 2022-03-29 Exercise | 2022-03-30 9:54 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 24,606 | $1.97 | 97,990 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:06 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | SHREWSBURY STEPHEN B Chief Medical Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:05 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | Paolillo Leonard Chief Commercial Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:04 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Fin. & Business Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:03 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:01 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President | 175,000 | $0 | 175,000 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:50 pm | N/A 2021-12-22 | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 20,000 | $0 | 128,221 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-23 4:50 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Hoekman John Chief Scientific Officer | 20,000 | $1.64 | 128,221 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 5:31 pm | N/A 2031-10-19 | IMPEL NEUROPHARMA INC | IMPL | Leaman John Harold Chief Fin. & Business Officer | 10,571 | $0 | 10,571 (Direct) | View |